Earnings Report Digest

Abbott Laboratories (ABT), 2025 Q2 earnings digest

1 min · 18. juli 2025
episode Abbott Laboratories (ABT), 2025 Q2 earnings digest cover

Beskrivelse

$ABT has released its Q2 2025 earnings, where EPS of $1.26 met expectations while revenue reached $11.14B, reflecting a 7.37% year-over-year increase. Despite a 1.5% decline in diagnostics sales, particularly in COVID testing, other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements, especially in diabetes care and biosimilars. 📊✹ For more details, check valueverge.com/ABT.

Kommentarer

0

VĂŠr den fĂžrste til at kommentere

Tilmeld dig nu og bliv en del af Earnings Report Digest-fĂŠllesskabet!

Kom i gang

1 mÄned kun 9 kr.

Derefter 99 kr. / mÄned · Opsig nÄr som helst.

  • Podcasts kun pĂ„ Podimo
  • 20 lydbogstimer pr. mĂ„ned
  • Gratis podcasts

Alle episoder

469 episoder